Bio Rad Laboratories Inc at Citigroup Inc Unplugged Medtech and Life Sciences Access Day Transcript
Thanks, everyone, for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. We have Norman Schwartz and Andy last with us from Bio-Rad. Guys, thanks for being here.
Questions & Answers
Maybe Norman, we can start off. You guys just finished -- just finished the year, kind of gave your initial '24 guidance range. Maybe just talk about, I guess, the general backdrop, what you guys are seeing as we head into '24 here and just general expectations for trends as we work our way through the year, and we can certainly dive into some specifics.
Yes. I think that, interestingly enough, we expected '23 to be a year of normalization. And I think we're looking at '24 now the year of normalization. We had that kind of the meltdown of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
